Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency.

The American journal of medicine - 1 Oct 2023

Riley Leonard, Sriram Aryaman, Brantly Mark, Lascano Jorge

Abstract excerpt

BACKGROUND: Alpha-1 antitrypsin deficiency is an under-recognized genetic cause of chronic lung and liver disease; it remains unclear what the testing frequency and disparities are for alpha-1 antitrypsin deficiency. METHODS: This is a retrospective cohort study of people with newly diagnosed chronic obstructive pulmonary disease and liver disease identified at the University of Florida between January 1, 2012...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin Deficiency
Share to Logistic Models
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pulmonary Disease, Chronic Obstructive

Source

Identifiers

PMID: 37451388
DOI: 10.1016/j.amjmed.2023.06.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency.PMID 37451388Read ↗

Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.Semantic proximity Read ↗

Testing Alpha-1 Antitrypsin Deficiency in Black Populations.Semantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

Epidemiology of Alpha-1 Antitrypsin Deficiency in the Veterans Health Administration.Semantic proximity Read ↗

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil.Semantic proximity Read ↗

The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Alpha1-antitrypsin deficiency: incidence and detection program.Semantic proximity Read ↗

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.Semantic proximity Read ↗

α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.Semantic proximity Read ↗

Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.Semantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.